Vallier L - Search Results

1

Naive Pluripotent Stem Cells Exhibit Phenotypic Variability that Is Driven by Genetic Variation.

Ortmann D, Brown S, Czechanski A, Aydin S, Muraro D, Huang Y, Tomaz RA, Osnato A, Canu G, Wesley BT, Skelly DA, Stegle O, Choi T, Churchill GA, Baker CL, Rugg-Gunn PJ, Munger SC, Reinholdt LG, Vallier L. Ortmann D, et al. Among authors: vallier l. Cell Stem Cell. 2020 Sep 3;27(3):470-481.e6. doi: 10.1016/j.stem.2020.07.019. Epub 2020 Aug 13. Cell Stem Cell. 2020. PMID: 32795399 Free PMC article.

2

Enhancing and diminishing gene function in human embryonic stem cells.

Vallier L, Rugg-Gunn PJ, Bouhon IA, Andersson FK, Sadler AJ, Pedersen RA. Vallier L, et al. Stem Cells. 2004;22(1):2-11. doi: 10.1634/stemcells.22-1-2. Stem Cells. 2004. PMID: 14688386

3

Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells.

Vallier L, Alexander M, Pedersen RA. Vallier L, et al. J Cell Sci. 2005 Oct 1;118(Pt 19):4495-509. doi: 10.1242/jcs.02553. J Cell Sci. 2005. PMID: 16179608

4

Human embryonic stem cells: an in vitro model to study mechanisms controlling pluripotency in early mammalian development.

Vallier L, Pedersen RA. Vallier L, et al. Stem Cell Rev. 2005;1(2):119-30. doi: 10.1385/SCR:1:2:119. Stem Cell Rev. 2005. PMID: 17142846 Review.

5

Derivation of pluripotent epiblast stem cells from mammalian embryos.

Brons IG, Smithers LE, Trotter MW, Rugg-Gunn P, Sun B, Chuva de Sousa Lopes SM, Howlett SK, Clarkson A, Ahrlund-Richter L, Pedersen RA, Vallier L. Brons IG, et al. Among authors: vallier l. Nature. 2007 Jul 12;448(7150):191-5. doi: 10.1038/nature05950. Epub 2007 Jun 27. Nature. 2007. PMID: 17597762

6

Differentiation of human embryonic stem cells in adherent and in chemically defined culture conditions.

Vallier L, Pedersen R. Vallier L, et al. Curr Protoc Stem Cell Biol. 2008 Mar;Chapter 1:Unit 1D.4.1-1D.4.7. doi: 10.1002/9780470151808.sc01d04s4. Curr Protoc Stem Cell Biol. 2008. PMID: 18770639

7

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.

Vallier L, Mendjan S, Brown S, Chng Z, Teo A, Smithers LE, Trotter MW, Cho CH, Martinez A, Rugg-Gunn P, Brons G, Pedersen RA. Vallier L, et al. Development. 2009 Apr;136(8):1339-49. doi: 10.1242/dev.033951. Epub 2009 Mar 11. Development. 2009. PMID: 19279133 Free PMC article.

8

Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways.

Vallier L, Touboul T, Chng Z, Brimpari M, Hannan N, Millan E, Smithers LE, Trotter M, Rugg-Gunn P, Weber A, Pedersen RA. Vallier L, et al. PLoS One. 2009 Jun 30;4(6):e6082. doi: 10.1371/journal.pone.0006082. PLoS One. 2009. PMID: 19564924 Free PMC article.

9

Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells.

Vallier L, Touboul T, Brown S, Cho C, Bilican B, Alexander M, Cedervall J, Chandran S, Ahrlund-Richter L, Weber A, Pedersen RA. Vallier L, et al. Stem Cells. 2009 Nov;27(11):2655-66. doi: 10.1002/stem.199. Stem Cells. 2009. PMID: 19688839

10

SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells.

Chng Z, Teo A, Pedersen RA, Vallier L. Chng Z, et al. Among authors: vallier l. Cell Stem Cell. 2010 Jan 8;6(1):59-70. doi: 10.1016/j.stem.2009.11.015. Cell Stem Cell. 2010. PMID: 20074535 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page